MXEQX
Price
$29.98
Change
+$1.92 (+6.84%)
Updated
Apr 9 closing price
Net Assets
1.49B
VIVAX
Price
$62.27
Change
-$1.68 (-2.63%)
Updated
Apr 10 closing price
Net Assets
190.51B
Ad is loading...

MXEQX vs VIVAX

Header iconMXEQX vs VIVAX Comparison
Open Charts MXEQX vs VIVAXBanner chart's image
Empower Large Cap Value I
Price$29.98
Change+$1.92 (+6.84%)
VolumeN/A
Net Assets1.49B
Vanguard Value Index I
Price$62.27
Change-$1.68 (-2.63%)
VolumeN/A
Net Assets190.51B
MXEQX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXEQX vs. VIVAX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEQX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. MXEQX (1.49B). VIVAX pays higher dividends than MXEQX: VIVAX (2.14) vs MXEQX (0.06). MXEQX was incepted earlier than VIVAX: MXEQX (30 years) vs VIVAX (32 years). MXEQX (0.98) is less costly to investors than VIVAX (0.17). MXEQX is a more actively managed with annual turnover of: 29.00 vs. VIVAX (10.00). MXEQX has a lower initial minimum investment than VIVAX: MXEQX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : -4.28 vs. MXEQX (-8.18). MXEQX return over 5 years is better than : 62.90 vs. VIVAX (58.34).
MXEQXVIVAXMXEQX / VIVAX
Total Expense Ratio0.960.17565%
Annual Report Gross Expense Ratio0.980.17576%
Fund Existence30 years32 years-
Gain YTD-9.014-9.13499%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B191B1%
Annual Yield % from dividends0.062.143%
Returns for 1 year-8.18-4.28191%
Returns for 3 years2.073.0768%
Returns for 5 years62.9058.34108%
Returns for 10 years51.4481.5163%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGHT2.350.26
+12.44%
Sight Sciences
REVG31.552.69
+9.32%
REV Group
CSGP78.735.50
+7.51%
CoStar Group
PFSI94.482.07
+2.24%
PennyMac Financial Services
BRNS0.69-0.03
-3.69%
Barinthus Biotherapeutics plc